← Open Payments lookup

BENJAMIN ROY: Open Payments

NPI 1013021492 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,049 in 109 payments from 12 companies in 2025. Trend: 2023 $890 · 2024 $1,362 · 2025 $2,049

Food & beverage: $2,049
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.13$291
E.R. Squibb & Sons, L.L.C.14$281
Vanda Pharmaceuticals Inc.15$242
Teva Pharmaceuticals USA, Inc.14$227
Otsuka America Pharmaceutical, Inc.11$226
Supernus Pharmaceuticals, Inc.12$176
Alkermes, Inc.9$175
Axsome Therapeutics, Inc.7$174
ABBVIE INC.6$96
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$81

Products named: INGREZZA, COBENFY, FANAPT, AUSTEDO XR, Qelbree, ARISTADA, Auvelity, ABILIFY MAINTENA.

Industry payments across GA — which companies pay providers there.